14 December 2022

At the AGM the company has confirmed that trading continues to be in line with expectations with a healthy pipeline of new business opportunities.  The company also remains in a healthy financial position with significant levels of net cash.  We continue to believe the shares are undervalued and that they are a BUY . . .

This content is restricted to members only. We offer three packages from 1 month to a whole year of daily tips, market news and commentary, plus our monthly newsletters.
Registration is quick and simple HERE.

Already a member, log in HERE.

Tagged: